Table 1

Demographic data of the patients who underwent COMET followed by limbal-rigid CL-wear therapy

CharacteristicsValue
Eyes/patients (n)23/18
Age (years)59±15
Gender: female:male12:6
Laterality
 Right eye8
 Left eye5
 Both5
Diagnosis (%)
 Stevens-Johnson syndrome16 (88.8%)
 Mucous membrane pemphigoid2 (11.2%)
Previous intervention (%)
 Eyelid procedure1 (4.3%)
 Symblepharon release2 (8.6%)
 AMT1 (4.3%)
 None19 (82.8%)
COMET indication (%)
 Corneal reconstruction for vision improvement10 (43.5%)
 Corneal reconstruction for persistent epithelial defect4 (17.4%)
 Conjunctival fornix reconstruction for release symblepharon9 (39.1%)
Additional procedure after COMET (%)
 Eyelid procedure2 (8.6%)
 Symblepharon release1 (4.3%)
 Penetrating keratoplasty1 (4.3%)
 Cataract1 (4.3%)
 Eyelid procedure + symblepharon release1 (4.3%)
 AMT + symblepharon release1 (4.3%)
 Cataract surgery + symblepharon release2 (8.6%)
 None14 (61.3%)
Mean follow-up period of limbal-rigid CL-wear (years)6.4±3.9
  • AMT, amniotic membrane transplantation; CL, contact lens; COMET, cultivated oral mucosal epithelial transplantation.